Neurological disorders include a wide spectrum of clinical conditions affecting the central and peripheral nervous systems. For these conditions, which affect hundreds of millions of people worldwide, generally limited or no treatments are available, and cell-based therapies have been intensively investigated in preclinical and clinical studies. Among the available cell types, mesenchymal stem/stromal cells (MSCs) have been widely studied but as yet no cell-based treatment exists for neurological disease. We review current knowledge of the therapeutic potential of MSC-based therapies for neurological diseases, as well as possible mechanisms of action that may be explored to hasten the development of new and effective treatments. We also discuss the challenges for culture conditions, quality control, and the development of potency tests, aiming to generate more efficient cell therapy products for neurological disorders.

Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases / Soares, M. B. P.; Goncalves, R. G. J.; Vasques, J. F.; da Silva-Junior, A. J.; Gubert, F.; Santos, G. C.; de Santana, T. A.; Almeida Sampaio, G. L.; Silva, D. N.; Dominici, M.; Mendez-Otero, R.. - In: FRONTIERS IN MOLECULAR NEUROSCIENCE. - ISSN 1662-5099. - 15:(2022), pp. 883378-N/A. [10.3389/fnmol.2022.883378]

Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases

Dominici M.;
2022-01-01

Abstract

Neurological disorders include a wide spectrum of clinical conditions affecting the central and peripheral nervous systems. For these conditions, which affect hundreds of millions of people worldwide, generally limited or no treatments are available, and cell-based therapies have been intensively investigated in preclinical and clinical studies. Among the available cell types, mesenchymal stem/stromal cells (MSCs) have been widely studied but as yet no cell-based treatment exists for neurological disease. We review current knowledge of the therapeutic potential of MSC-based therapies for neurological diseases, as well as possible mechanisms of action that may be explored to hasten the development of new and effective treatments. We also discuss the challenges for culture conditions, quality control, and the development of potency tests, aiming to generate more efficient cell therapy products for neurological disorders.
15
883378
N/A
Current Status of Mesenchymal Stem/Stromal Cells for Treatment of Neurological Diseases / Soares, M. B. P.; Goncalves, R. G. J.; Vasques, J. F.; da Silva-Junior, A. J.; Gubert, F.; Santos, G. C.; de Santana, T. A.; Almeida Sampaio, G. L.; Silva, D. N.; Dominici, M.; Mendez-Otero, R.. - In: FRONTIERS IN MOLECULAR NEUROSCIENCE. - ISSN 1662-5099. - 15:(2022), pp. 883378-N/A. [10.3389/fnmol.2022.883378]
Soares, M. B. P.; Goncalves, R. G. J.; Vasques, J. F.; da Silva-Junior, A. J.; Gubert, F.; Santos, G. C.; de Santana, T. A.; Almeida Sampaio, G. L.; Silva, D. N.; Dominici, M.; Mendez-Otero, R.
File in questo prodotto:
File Dimensione Formato  
fnmol-15-883378.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 1.13 MB
Formato Adobe PDF
1.13 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1288294
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact